SLEEP NUMBER CORP (SNBR) Fundamental Analysis & Valuation

NASDAQ:SNBR • US83125X1037

Current stock price

2.36 USD
-0.1 (-4.07%)
At close:
2.27 USD
-0.09 (-3.81%)
After Hours:

This SNBR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SNBR Profitability Analysis

1.1 Basic Checks

  • SNBR had negative earnings in the past year.
  • In the past year SNBR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
  • In multiple years SNBR reported negative operating cash flow during the last 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of SNBR (-19.40%) is worse than 81.30% of its industry peers.
  • SNBR has a Return On Invested Capital (4.07%) which is in line with its industry peers.
  • SNBR had an Average Return On Invested Capital over the past 3 years of 5.01%. This is significantly below the industry average of 13.57%.
Industry RankSector Rank
ROA -19.4%
ROE N/A
ROIC 4.07%
ROA(3y)-7.79%
ROA(5y)-0.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.01%
ROIC(5y)12.96%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

1.3 Margins

  • SNBR has a Operating Margin (1.30%) which is in line with its industry peers.
  • SNBR's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 59.69%, SNBR belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
  • SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.3%
PM (TTM) N/A
GM 59.69%
OM growth 3Y-32.94%
OM growth 5Y-37.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y-0.84%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SNBR Health Analysis

2.1 Basic Checks

  • SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SNBR has been increased compared to 1 year ago.
  • Compared to 5 years ago, SNBR has less shares outstanding
  • SNBR has a worse debt/assets ratio than last year.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -0.41, we must say that SNBR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.41, SNBR is doing worse than 80.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.41
ROIC/WACC0.52
WACC7.81%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that SNBR may have some problems paying its short term obligations.
  • SNBR has a Current ratio of 0.16. This is amonst the worse of the industry: SNBR underperforms 95.12% of its industry peers.
  • SNBR has a Quick Ratio of 0.16. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.07, SNBR is doing worse than 95.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.07
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SNBR Growth Analysis

3.1 Past

  • The earnings per share for SNBR have decreased strongly by -492.22% in the last year.
  • The Revenue for SNBR has decreased by -16.10% in the past year. This is quite bad
  • SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.34% yearly.
EPS 1Y (TTM)-492.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-914.29%
Revenue 1Y (TTM)-16.1%
Revenue growth 3Y-12.6%
Revenue growth 5Y-5.34%
Sales Q2Q%-7.81%

3.2 Future

  • SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.62% yearly.
  • SNBR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.40% yearly.
EPS Next Y90.14%
EPS Next 2Y44.37%
EPS Next 3Y29.62%
EPS Next 5YN/A
Revenue Next Year-1.97%
Revenue Next 2Y2.4%
Revenue Next 3Y3.4%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. SNBR Valuation Analysis

4.1 Price/Earnings Ratio

  • SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SNBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 99.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.74
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNBR's earnings are expected to grow with 29.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.37%
EPS Next 3Y29.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNBR Dividend Analysis

5.1 Amount

  • No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNBR Fundamentals: All Metrics, Ratios and Statistics

SLEEP NUMBER CORP

NASDAQ:SNBR (4/24/2026, 8:08:53 PM)

After market: 2.27 -0.09 (-3.81%)

2.36

-0.1 (-4.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-12
Earnings (Next)04-29
Inst Owners84.14%
Inst Owner Change0.05%
Ins Owners8.59%
Ins Owner Change21.09%
Market Cap54.37M
Revenue(TTM)1.41B
Net Income(TTM)-131.96M
Analysts48.89
Price Target4.59 (94.49%)
Short Float %28.04%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-627.61%
Min EPS beat(2)-937.57%
Max EPS beat(2)-317.65%
EPS beat(4)0
Avg EPS beat(4)-900.39%
Min EPS beat(4)-1452.29%
Max EPS beat(4)-317.65%
EPS beat(8)3
Avg EPS beat(8)-447.34%
EPS beat(12)5
Avg EPS beat(12)-282.15%
EPS beat(16)7
Avg EPS beat(16)-190.68%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-7.26%
Max Revenue beat(2)3.62%
Revenue beat(4)1
Avg Revenue beat(4)-4.2%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)3.62%
Revenue beat(8)1
Avg Revenue beat(8)-4.31%
Revenue beat(12)2
Avg Revenue beat(12)-4.3%
Revenue beat(16)4
Avg Revenue beat(16)-3.13%
PT rev (1m)-59.09%
PT rev (3m)-18.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-115.28%
EPS NY rev (1m)-7.29%
EPS NY rev (3m)-5.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 0.74
EPS(TTM)-5.33
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS61.26
BVpS-25.11
TBVpS-27.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -19.4%
ROE N/A
ROCE -7.89%
ROIC 4.07%
ROICexc 4.09%
ROICexgc 5.03%
OM 1.3%
PM (TTM) N/A
GM 59.69%
FCFM N/A
ROA(3y)-7.79%
ROA(5y)-0.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.01%
ROIC(5y)12.96%
ROICexc(3y)5.03%
ROICexc(5y)13.03%
ROICexgc(3y)5.85%
ROICexgc(5y)15.59%
ROCE(3y)56.17%
ROCE(5y)394.78%
ROICexgc growth 3Y-33.85%
ROICexgc growth 5Y-39.66%
ROICexc growth 3Y-35.05%
ROICexc growth 5Y-39.62%
OM growth 3Y-32.94%
OM growth 5Y-37.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y-0.84%
F-Score5
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.95
Cap/Depr 25.91%
Cap/Sales 1.02%
Interest Coverage 0.36
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.07
Altman-Z -0.41
F-Score5
WACC7.81%
ROIC/WACC0.52
Cap/Depr(3y)46.13%
Cap/Depr(5y)70.45%
Cap/Sales(3y)1.81%
Cap/Sales(5y)2.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-492.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-914.29%
EPS Next Y90.14%
EPS Next 2Y44.37%
EPS Next 3Y29.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.1%
Revenue growth 3Y-12.6%
Revenue growth 5Y-5.34%
Sales Q2Q%-7.81%
Revenue Next Year-1.97%
Revenue Next 2Y2.4%
Revenue Next 3Y3.4%
Revenue Next 5YN/A
EBIT growth 1Y-55.21%
EBIT growth 3Y-41.39%
EBIT growth 5Y-40.6%
EBIT Next Year657.04%
EBIT Next 3Y116.2%
EBIT Next 5YN/A
FCF growth 1Y-586.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.09%
OCF growth 3YN/A
OCF growth 5YN/A

SLEEP NUMBER CORP / SNBR Fundamental Analysis FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNBR.


What is the valuation status for SNBR stock?

ChartMill assigns a valuation rating of 1 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


How profitable is SLEEP NUMBER CORP (SNBR) stock?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 2 / 10.